Review



cleaved casp1 mouse  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    Cell Signaling Technology Inc cleaved casp1 mouse
    Fig. 3. SSA Suppresses Mtb-Induced Pyroptosis. *p < 0.05, **p < 0.01, ***p < 0.001. NS, nonsignificant. (A, B, C, D) Changes in NLRP3 protein levels were evaluated with Western blotting following Mtb infection in macrophages. (E, F) Protein samples from various treatment groups were cross-linked with DSS and analyzed with Western blotting, revealing monomeric, dimeric, and oligomeric forms of ASC (n = 3). (I, J) Co-immunoprecipitation of ASC followed by immunoblotting for NLRP3 and ASC, with subsequent reblotting for NLRP3 and ASC. One representative experiment of three is shown. (K, l) Changes in <t>CASP1</t> (p20) and GSDMD-N protein levels were evaluated with Western blotting after cells were treated with 8 μM SSA for 6, 12, or 24 h following 4 h of Mtb infection. (G, H) IL-1β levels were measured using ELISA (n = 3) after cells were treated with 2-8 μM SSA for 12 h following 4 h of Mtb infection.
    Cleaved Casp1 Mouse, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 467 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cleaved casp1 mouse/product/Cell Signaling Technology Inc
    Average 97 stars, based on 467 article reviews
    cleaved casp1 mouse - by Bioz Stars, 2026-02
    97/100 stars

    Images

    1) Product Images from "Saikosaponin A targets HDAC6 to inhibit Mycobacterium tuberculosis-induced macrophage Pyroptosis via autophagy-mediated NLRP3 inflammasome inactivation."

    Article Title: Saikosaponin A targets HDAC6 to inhibit Mycobacterium tuberculosis-induced macrophage Pyroptosis via autophagy-mediated NLRP3 inflammasome inactivation.

    Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

    doi: 10.1016/j.phymed.2025.156693

    Fig. 3. SSA Suppresses Mtb-Induced Pyroptosis. *p < 0.05, **p < 0.01, ***p < 0.001. NS, nonsignificant. (A, B, C, D) Changes in NLRP3 protein levels were evaluated with Western blotting following Mtb infection in macrophages. (E, F) Protein samples from various treatment groups were cross-linked with DSS and analyzed with Western blotting, revealing monomeric, dimeric, and oligomeric forms of ASC (n = 3). (I, J) Co-immunoprecipitation of ASC followed by immunoblotting for NLRP3 and ASC, with subsequent reblotting for NLRP3 and ASC. One representative experiment of three is shown. (K, l) Changes in CASP1 (p20) and GSDMD-N protein levels were evaluated with Western blotting after cells were treated with 8 μM SSA for 6, 12, or 24 h following 4 h of Mtb infection. (G, H) IL-1β levels were measured using ELISA (n = 3) after cells were treated with 2-8 μM SSA for 12 h following 4 h of Mtb infection.
    Figure Legend Snippet: Fig. 3. SSA Suppresses Mtb-Induced Pyroptosis. *p < 0.05, **p < 0.01, ***p < 0.001. NS, nonsignificant. (A, B, C, D) Changes in NLRP3 protein levels were evaluated with Western blotting following Mtb infection in macrophages. (E, F) Protein samples from various treatment groups were cross-linked with DSS and analyzed with Western blotting, revealing monomeric, dimeric, and oligomeric forms of ASC (n = 3). (I, J) Co-immunoprecipitation of ASC followed by immunoblotting for NLRP3 and ASC, with subsequent reblotting for NLRP3 and ASC. One representative experiment of three is shown. (K, l) Changes in CASP1 (p20) and GSDMD-N protein levels were evaluated with Western blotting after cells were treated with 8 μM SSA for 6, 12, or 24 h following 4 h of Mtb infection. (G, H) IL-1β levels were measured using ELISA (n = 3) after cells were treated with 2-8 μM SSA for 12 h following 4 h of Mtb infection.

    Techniques Used: Western Blot, Infection, Immunoprecipitation, Enzyme-linked Immunosorbent Assay



    Similar Products

    97
    Cell Signaling Technology Inc cleaved casp1 mouse
    Fig. 3. SSA Suppresses Mtb-Induced Pyroptosis. *p < 0.05, **p < 0.01, ***p < 0.001. NS, nonsignificant. (A, B, C, D) Changes in NLRP3 protein levels were evaluated with Western blotting following Mtb infection in macrophages. (E, F) Protein samples from various treatment groups were cross-linked with DSS and analyzed with Western blotting, revealing monomeric, dimeric, and oligomeric forms of ASC (n = 3). (I, J) Co-immunoprecipitation of ASC followed by immunoblotting for NLRP3 and ASC, with subsequent reblotting for NLRP3 and ASC. One representative experiment of three is shown. (K, l) Changes in <t>CASP1</t> (p20) and GSDMD-N protein levels were evaluated with Western blotting after cells were treated with 8 μM SSA for 6, 12, or 24 h following 4 h of Mtb infection. (G, H) IL-1β levels were measured using ELISA (n = 3) after cells were treated with 2-8 μM SSA for 12 h following 4 h of Mtb infection.
    Cleaved Casp1 Mouse, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cleaved casp1 mouse/product/Cell Signaling Technology Inc
    Average 97 stars, based on 1 article reviews
    cleaved casp1 mouse - by Bioz Stars, 2026-02
    97/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc anti pro casp1 anti casp1 p20 antibody mouse
    AI-Cells controlled liver injury by inhibiting macrophage NLRP3 inflammasome activation and reducing IL-1β production (A) The levels of IL-1β, TNF-α, and IL-6 in the supernatant of BMDMs/Kupffer cells in various groups (n = 3 biological replicates). (B) Schematic representation of a BMDM/Kupffer cell inflammation model responding to TNF-α, IL-6, and IL-1β. AI-Cell treatment significantly reduced the concentration of IL-1β but had no significant effect on TNF-α and IL-6. (C) Quantification of viable AML-12 cells after IL-1β exposure (n = 5 biological replicates). The AML-12 cells were cultured in the B-AI-Cells CM supplemented with recombinant IL-1β. B-LPS&ATP CM was set up as a control. (D) Survival of AML-12 cells after K-LPS&ATP CM and IL-1β antibody exposure (n = 3 biological replicates). K-LPS&ATP CM was set up as a control. (E) Representative microscopy images of AML-12 cells treated with various conditioned medium from Kupffer cells and stained with crystal violet. Scale bars: 1,000 μm. (F) Western blot of NLRP3, pro-Casp1, Casp1 <t>p20,</t> and β-actin with protein lysates from liver tissues of sham, APAP, and AI cells groups. (G) Western blot of IL-1β with protein lysates from liver tissues of sham, APAP, and AI-Cells groups. (H–K) Densitometric analysis of NLRP3, pro-Casp1, Casp1 p20, and IL-1β proteins by ImageJ software (n = 3 biological replicates). (L) IL-1β staining of liver tissues from the sham, APAP, or AI-Cell-treated ALF mice after euthanasia. Scale bars: 200 μm. (M) Schematic diagram of AI-Cells blocking activation of NLPR3 inflammasome. (N) Docking mode of NLRP3 (white surface and green cartoon) with itaconic acid (cyan sticks). (O) Three-dimensional (3D) interaction mode of NLRP3 (green cartoon) and itaconic acid (cyan sticks). The key residues are shown as green sticks and the hydrogen bond is shown in yellow dashed lines. All data are expressed as mean ± SD; ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001, and ns is p > 0.05 by one-way ANOVA.
    Anti Pro Casp1 Anti Casp1 P20 Antibody Mouse, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti pro casp1 anti casp1 p20 antibody mouse/product/Cell Signaling Technology Inc
    Average 97 stars, based on 1 article reviews
    anti pro casp1 anti casp1 p20 antibody mouse - by Bioz Stars, 2026-02
    97/100 stars
      Buy from Supplier

    Image Search Results


    Fig. 3. SSA Suppresses Mtb-Induced Pyroptosis. *p < 0.05, **p < 0.01, ***p < 0.001. NS, nonsignificant. (A, B, C, D) Changes in NLRP3 protein levels were evaluated with Western blotting following Mtb infection in macrophages. (E, F) Protein samples from various treatment groups were cross-linked with DSS and analyzed with Western blotting, revealing monomeric, dimeric, and oligomeric forms of ASC (n = 3). (I, J) Co-immunoprecipitation of ASC followed by immunoblotting for NLRP3 and ASC, with subsequent reblotting for NLRP3 and ASC. One representative experiment of three is shown. (K, l) Changes in CASP1 (p20) and GSDMD-N protein levels were evaluated with Western blotting after cells were treated with 8 μM SSA for 6, 12, or 24 h following 4 h of Mtb infection. (G, H) IL-1β levels were measured using ELISA (n = 3) after cells were treated with 2-8 μM SSA for 12 h following 4 h of Mtb infection.

    Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

    Article Title: Saikosaponin A targets HDAC6 to inhibit Mycobacterium tuberculosis-induced macrophage Pyroptosis via autophagy-mediated NLRP3 inflammasome inactivation.

    doi: 10.1016/j.phymed.2025.156693

    Figure Lengend Snippet: Fig. 3. SSA Suppresses Mtb-Induced Pyroptosis. *p < 0.05, **p < 0.01, ***p < 0.001. NS, nonsignificant. (A, B, C, D) Changes in NLRP3 protein levels were evaluated with Western blotting following Mtb infection in macrophages. (E, F) Protein samples from various treatment groups were cross-linked with DSS and analyzed with Western blotting, revealing monomeric, dimeric, and oligomeric forms of ASC (n = 3). (I, J) Co-immunoprecipitation of ASC followed by immunoblotting for NLRP3 and ASC, with subsequent reblotting for NLRP3 and ASC. One representative experiment of three is shown. (K, l) Changes in CASP1 (p20) and GSDMD-N protein levels were evaluated with Western blotting after cells were treated with 8 μM SSA for 6, 12, or 24 h following 4 h of Mtb infection. (G, H) IL-1β levels were measured using ELISA (n = 3) after cells were treated with 2-8 μM SSA for 12 h following 4 h of Mtb infection.

    Article Snippet: For antibodies, we applied NLRP3 (Cat# 15,101, CST), NLRP3 (Cat# A21906, Abclonal), GSDMD (Cat# 39,754, CST), cleaved CASP1 (mouse) (Cat# 89,332, CST), cleaved CASP1 (human) (Cat# AG-20B0048-C100, AdipoGen), HDAC6 (Cat# 7612, CST), LC3B (Cat# 43,566, CST), LC3B Mouse mAb (Cat# A17424, Abclonal), LC3B (Cat# SC-271,625 Santa Cruz), p62(Cat# A11250, Abclonal), mTOR (Cat# 2972, CST), p-mTOR (Cat# 5536, CST), p-ULK1 Ser757 (Cat# 14,202, CST), p-ULK1 Ser555 (Cat# 5869, CST), ULK1 (Cat# 8054, CST), AMPKα (Cat# 5831, CST), p-AMPKα Thr172 (Cat# 2535, CST), Alexa Fluor 594-conjugated goat anti-mouse IgG (Cat# 8890S, CST), Alexa Fluor 488 goat anti-rabbit IgG (Cat# AS053, Abclonal), β-actin (Cat# CL594–66,009, ProteinTech), ASC (Cat# SC-514,414, Santa Cruz), ASC (Cat# A16672, Abclonal), HRP-conjugated AffiniPure Mouse AntiRabbit IgG Light Chain (Cat# AS061, Abclonal), alpha-tubulin (acetyl K40) (Cat# ab179484, Abcam), Acetyl-α-tubulin (Lys K40) (Cat# 5335, CST), and DYKDDDDK Tag (D6W5B) Rabbit mAb (Cat# 14,793, CST).

    Techniques: Western Blot, Infection, Immunoprecipitation, Enzyme-linked Immunosorbent Assay

    AI-Cells controlled liver injury by inhibiting macrophage NLRP3 inflammasome activation and reducing IL-1β production (A) The levels of IL-1β, TNF-α, and IL-6 in the supernatant of BMDMs/Kupffer cells in various groups (n = 3 biological replicates). (B) Schematic representation of a BMDM/Kupffer cell inflammation model responding to TNF-α, IL-6, and IL-1β. AI-Cell treatment significantly reduced the concentration of IL-1β but had no significant effect on TNF-α and IL-6. (C) Quantification of viable AML-12 cells after IL-1β exposure (n = 5 biological replicates). The AML-12 cells were cultured in the B-AI-Cells CM supplemented with recombinant IL-1β. B-LPS&ATP CM was set up as a control. (D) Survival of AML-12 cells after K-LPS&ATP CM and IL-1β antibody exposure (n = 3 biological replicates). K-LPS&ATP CM was set up as a control. (E) Representative microscopy images of AML-12 cells treated with various conditioned medium from Kupffer cells and stained with crystal violet. Scale bars: 1,000 μm. (F) Western blot of NLRP3, pro-Casp1, Casp1 p20, and β-actin with protein lysates from liver tissues of sham, APAP, and AI cells groups. (G) Western blot of IL-1β with protein lysates from liver tissues of sham, APAP, and AI-Cells groups. (H–K) Densitometric analysis of NLRP3, pro-Casp1, Casp1 p20, and IL-1β proteins by ImageJ software (n = 3 biological replicates). (L) IL-1β staining of liver tissues from the sham, APAP, or AI-Cell-treated ALF mice after euthanasia. Scale bars: 200 μm. (M) Schematic diagram of AI-Cells blocking activation of NLPR3 inflammasome. (N) Docking mode of NLRP3 (white surface and green cartoon) with itaconic acid (cyan sticks). (O) Three-dimensional (3D) interaction mode of NLRP3 (green cartoon) and itaconic acid (cyan sticks). The key residues are shown as green sticks and the hydrogen bond is shown in yellow dashed lines. All data are expressed as mean ± SD; ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001, and ns is p > 0.05 by one-way ANOVA.

    Journal: Cell Reports Medicine

    Article Title: Artificial cells delivering itaconic acid induce anti-inflammatory memory-like macrophages to reverse acute liver failure and prevent reinjury

    doi: 10.1016/j.xcrm.2023.101132

    Figure Lengend Snippet: AI-Cells controlled liver injury by inhibiting macrophage NLRP3 inflammasome activation and reducing IL-1β production (A) The levels of IL-1β, TNF-α, and IL-6 in the supernatant of BMDMs/Kupffer cells in various groups (n = 3 biological replicates). (B) Schematic representation of a BMDM/Kupffer cell inflammation model responding to TNF-α, IL-6, and IL-1β. AI-Cell treatment significantly reduced the concentration of IL-1β but had no significant effect on TNF-α and IL-6. (C) Quantification of viable AML-12 cells after IL-1β exposure (n = 5 biological replicates). The AML-12 cells were cultured in the B-AI-Cells CM supplemented with recombinant IL-1β. B-LPS&ATP CM was set up as a control. (D) Survival of AML-12 cells after K-LPS&ATP CM and IL-1β antibody exposure (n = 3 biological replicates). K-LPS&ATP CM was set up as a control. (E) Representative microscopy images of AML-12 cells treated with various conditioned medium from Kupffer cells and stained with crystal violet. Scale bars: 1,000 μm. (F) Western blot of NLRP3, pro-Casp1, Casp1 p20, and β-actin with protein lysates from liver tissues of sham, APAP, and AI cells groups. (G) Western blot of IL-1β with protein lysates from liver tissues of sham, APAP, and AI-Cells groups. (H–K) Densitometric analysis of NLRP3, pro-Casp1, Casp1 p20, and IL-1β proteins by ImageJ software (n = 3 biological replicates). (L) IL-1β staining of liver tissues from the sham, APAP, or AI-Cell-treated ALF mice after euthanasia. Scale bars: 200 μm. (M) Schematic diagram of AI-Cells blocking activation of NLPR3 inflammasome. (N) Docking mode of NLRP3 (white surface and green cartoon) with itaconic acid (cyan sticks). (O) Three-dimensional (3D) interaction mode of NLRP3 (green cartoon) and itaconic acid (cyan sticks). The key residues are shown as green sticks and the hydrogen bond is shown in yellow dashed lines. All data are expressed as mean ± SD; ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001, and ns is p > 0.05 by one-way ANOVA.

    Article Snippet: Anti-pro-Casp1/anti-Casp1 p20 antibody (mouse) , Cell Signaling Technology , Cat# 89332; RRID: AB_2923067.

    Techniques: Activation Assay, Concentration Assay, Cell Culture, Recombinant, Control, Microscopy, Staining, Western Blot, Software, Blocking Assay

    Journal: Cell Reports Medicine

    Article Title: Artificial cells delivering itaconic acid induce anti-inflammatory memory-like macrophages to reverse acute liver failure and prevent reinjury

    doi: 10.1016/j.xcrm.2023.101132

    Figure Lengend Snippet:

    Article Snippet: Anti-pro-Casp1/anti-Casp1 p20 antibody (mouse) , Cell Signaling Technology , Cat# 89332; RRID: AB_2923067.

    Techniques: Recombinant, RNA Extraction, Staining, Real-time Polymerase Chain Reaction, Software